Skip to main content
. 2023 Sep 11;15(17):9086–9104. doi: 10.18632/aging.205018

Figure 10.

Figure 10

SH2D4A affects proliferation and migration of glioma cells. (A) Immunohistochemical staining of SH2D4A in glioma (data from HPA). (B, C) qRT-PCR and western blot analysis of SH2D4A knockdown efficiency in U87 MG cells. (D) Analysis of proliferation of control and SH2D4A-deficient U87 MG cells by CCK8 assay. (E, F) Representative images and statistical analysis of EdU assay in control and SH2D4A-deficient U87 MG cells. (G, H) Representative images and statistical analysis of cell migration assay in control and SH2D4A-deficient U87 MG cells at the indicated times. **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.